{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:50Z","timestamp":1787020790674,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1320-2","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T05:02:31Z","timestamp":1561006951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Hoon Sik","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Seok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Mun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-ock","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"1320_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1023\/B:CACO.0000024222.61114.18","volume":"15","author":"PA Wingo","year":"2004","unstructured":"Wingo PA, Jamison PM, Young JL, Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes Control. 2004;15:321\u20138.","journal-title":"Cancer Causes Control"},{"key":"1320_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/COC.0b013e31817b6073","volume":"32","author":"MC Abramowitz","year":"2009","unstructured":"Abramowitz MC, Li T, Morrow M, Sigurdson ER, Anderson P, Nicolaou N, Freedman G. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation. Am J Clin Oncol. 2009;32:30\u20133.","journal-title":"Am J Clin Oncol"},{"key":"1320_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","volume":"72","author":"IJ Bristol","year":"2008","unstructured":"Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, et al. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2008;72:474\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1320_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ijrobp.2014.01.054","volume":"89","author":"L Brown","year":"2014","unstructured":"Brown L, Harmsen W, Blanchard M, Goetz M, Jakub J, Mutter R, Petersen I, Rooney J, Stauder M, Yan E, et al. Once-daily radiation therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2014;89:997\u20131003.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1320_CR5","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.21873\/anticanres.11024","volume":"36","author":"P Vempati","year":"2016","unstructured":"Vempati P, Knoll MA, Dharmarajan K, Green S, Tiersten A, Bakst RL. Palliation of ulcerative breast lesions with radiation. Anticancer Res. 2016;36:4701\u20135.","journal-title":"Anticancer Res"},{"key":"1320_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clbc.2014.05.005","volume":"15","author":"JM Matro","year":"2015","unstructured":"Matro JM, Li T, Cristofanilli M, Hughes ME, Ottesen RA, Weeks JC, Wong YN. Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome. Clin Breast Cancer. 2015;15:1\u20137.","journal-title":"Clin Breast Cancer"},{"key":"1320_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0360-3016(00)00561-7","volume":"47","author":"Z Liao","year":"2000","unstructured":"Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, McNeese MD. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys. 2000;47:1191\u2013200.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1320_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ijrobp.2009.05.013","volume":"75","author":"GA Plataniotis","year":"2009","unstructured":"Plataniotis GA, Dale RG. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2009;75:512\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1320_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1445-5994.1998.tb01974.x","volume":"28","author":"H Gurney","year":"1998","unstructured":"Gurney H, Harnett P, Kefford R, Boyages J. Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin. Aust NZ J Med. 1998;28:400\u20132.","journal-title":"Aust NZ J Med"},{"key":"1320_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00000421-199210000-00002","volume":"15","author":"TM Pisansky","year":"1992","unstructured":"Pisansky TM, Schaid DJ, Loprinzi CL, Donohue JH, Schray MF, Schomberg PJ. Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol. 1992;15:376\u201387.","journal-title":"Am J Clin Oncol"},{"key":"1320_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, et al. The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086\u201394.","journal-title":"Lancet Oncol"},{"key":"1320_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","volume":"7","author":"JR Owen","year":"2006","unstructured":"Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, Haviland J, Bentzen SM, Yarnold JR. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7:467\u201371.","journal-title":"Lancet Oncol."},{"key":"1320_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320.","journal-title":"N Engl J Med"},{"key":"1320_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/annonc\/mdq345","volume":"22","author":"S Dawood","year":"2011","unstructured":"Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515\u201323.","journal-title":"Ann Oncol"},{"key":"1320_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/jclinpath-2018-205255","volume":"71","author":"C Quinn","year":"2018","unstructured":"Quinn C, Rakha EA. Eighth edition Cancer staging manual of breast Cancer by the American joint committee on Cancer: are the new changes to improve staging or a treatment decision tool? J Clin Pathol. 2018;71:1028\u20139.","journal-title":"J Clin Pathol"},{"key":"1320_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"JF Fowler","year":"1989","unstructured":"Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679\u201394.","journal-title":"Br J Radiol"},{"key":"1320_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.radonc.2008.06.007","volume":"89","author":"JP Agarwal","year":"2008","unstructured":"Agarwal JP, Nemade B, Murthy V, Ghosh-Laskar S, Budrukkar A, Gupta T, D'Cruz A, Pai P, Chaturvedi P, Dinshaw K. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol. 2008;89:51\u20136.","journal-title":"Radiother Oncol"},{"key":"1320_CR18","first-page":"e316","volume":"63","author":"A Landry","year":"2017","unstructured":"Landry A, Docherty P, Ouellette S, Cartier LJ. Causes and outcomes of markedly elevated C-reactive protein levels. Can Fam Physician. 2017;63:e316\u2013e23.","journal-title":"Can Fam Physician"},{"key":"1320_CR19","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1200\/JCO.2017.77.1790","volume":"36","author":"JJ Hu","year":"2018","unstructured":"Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, Langefeld CD, Lively MO, Mitchell SE, Thakrar A, et al. Association between inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in a multiracial\/ethnic breast Cancer population. J Clin Oncol. 2018;36:2473\u201382.","journal-title":"J Clin Oncol"},{"key":"1320_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/1097-0142(19810501)47:9<2232::AID-CNCR2820470921>3.0.CO;2-R","volume":"47","author":"JM Bedwinek","year":"1981","unstructured":"Bedwinek JM, Lee J, Fineberg B, Ocwieza M. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer. 1981;47:2232\u20135.","journal-title":"Cancer"},{"key":"1320_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0936-6555(05)81054-4","volume":"4","author":"A Price","year":"1992","unstructured":"Price A, Kerr GR, Rodger A. Primary radiotherapy for T4 breast cancer. Clin Oncol (R Coll Radiol). 1992;4:217\u201321.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1320_CR22","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1200\/JCO.2014.55.1143","volume":"32","author":"ST Lutz","year":"2014","unstructured":"Lutz ST, Jones J, Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol. 2014;32:2913\u20139.","journal-title":"J Clin Oncol"},{"key":"1320_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0973-1075.116709","volume":"19","author":"S Das","year":"2013","unstructured":"Das S, Thomas S, Pal SK, Isiah R, John S. Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck Cancer: CMC Vellore experience. Indian J Palliat Care. 2013;19:93\u20138.","journal-title":"Indian J Palliat Care"},{"key":"1320_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0360-3016(00)00430-2","volume":"47","author":"GM Duchesne","year":"2000","unstructured":"Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, Fossa SD, Uscinska BM, Parmar MK. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int J Radiat Oncol Biol Phys. 2000;47:379\u201388.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1320_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1200\/JCO.2004.06.123","volume":"22","author":"S Sundstrom","year":"2004","unstructured":"Sundstrom S, Bremnes R, Aasebo U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol. 2004;22:801\u201310.","journal-title":"J Clin Oncol"},{"key":"1320_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3857\/roj.2016.01697","volume":"34","author":"KS Kim","year":"2016","unstructured":"Kim KS, Shin KH, Choi N, Lee SW. Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery. Radiat Oncol J. 2016;34:81\u20137.","journal-title":"Radiat Oncol J"},{"key":"1320_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5301\/tj.5000511","volume":"102","author":"L Deantonio","year":"2016","unstructured":"Deantonio L, Cozzi S, Tunesi S, Brambilla M, Masini L, Pisani C, Gambaro G, Magnani C, Krengli M. Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients. Tumori. 2016;102:398\u2013403.","journal-title":"Tumori"},{"key":"1320_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/jjco\/hyy054","volume":"48","author":"N Nakamura","year":"2018","unstructured":"Nakamura N, Kawamori J, Takahashi O, Shikama N, Sekiguchi K, Takahashi T, Kato S, Ogita M, Motegi A, Akimoto T. Palliative radiotherapy for breast cancer patients with skin invasion: a multi-institutional prospective observational study. Jpn J Clin Oncol. 2018;48:555\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1320_CR29","first-page":"1712","volume":"6","author":"AS Vekaria","year":"2017","unstructured":"Vekaria AS, Brunner PM, Aleisa AI, Bonomo L, Lebwohl MG, Israel A, Guttman-Yassky E. Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity. F1000Res. 2017;6:1712.","journal-title":"F1000Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1320-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T19:12:02Z","timestamp":1592507522000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1320-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1320-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was a retrospective study with no informed consent from the individual patient, but was performed according to the relevant guidelines and protocol approved by the intra-institutional ethics committee of the Seoul St. Mary\u2019s hospital (assigned number: KC15RISI0260).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable because this analysis has retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}